The faster-spreading B.1.1.7 variant of SARS-CoV-2 first detected in the United Kingdom, the coronavirus that causes COVID-19, is quickly on its way to becoming the dominant variant of the virus in the...

An investigational vaccine designed to protect against the B.1.351 SARS-CoV-2 variant has been administered as part of a new Phase 1 clinical trial evaluating the vaccine candidate’s safety and immunogenicity...

In a study that looked at racial differences in outcomes of COVID-19 patients admitted to the intensive care unit, researchers at Henry Ford Hospital in Detroit found that patients of color had a lower...

By NewsDesk  @infectiousdiseasenews The civil association, Médicos Unidos Venezuela reported another fifteen health workers died in Venezuela from COVID-19 between the 26th and 28th of this month, bringing...

By NewsDesk  @infectiousdiseasenews The Vietnam Food Administration is reporting at least one botulism death and several suspected cases in localities such as Kon Tum province and Binh Duong province. The...

Today, the U.S. Food and Drug Administration announced it is allowing the use of the Binx Health IO CT/NG Assay at point-of-care settings, such as in physician offices, community-based clinics, urgent...

Takeda Pharmaceutical Company announced recently that the European Medicines Agency (EMA) has accepted the Company’s filing packages for its dengue vaccine candidate (TAK-003) which is being investigated...

By NewsDesk  @infectiousdiseasenews The Department of Public Health Mid-West is reporting an outbreak of Verotoxigenic E. coli (VTEC) in a single setting of children in the Mid-West region of Ireland. Health...

By NewsDesk  @infectiousdiseasenews A report from the Swedish Public Health Agency shows that of the several hundred thousand people in Sweden who have received two COVID-19 vaccine doses and about 200...

By NewsDesk  @infectiousdiseasenews The Canadian National Advisory Committee on Immunization (NACI) Monday recommended that the AstraZeneca COVID-19 vaccine should not be used in adults under 55 years...